1. Combined hepatocellular-cholangiocarcinoma successfully treated with sorafenib: case report and review of the literature
   Yuka Futsukaichi et al, 2019, Clinical Journal of Gastroenterology CrossRef
2. Hepatocellular carcinoma treatment with Sorafenib: A remarkable case of eight-years remission without significant toxicity
   Ana L. Santos et al, 2021, Annals of Hepatology CrossRef
3. State-of-the-art Review: Interventional Onco-Cardiology
   Bala Pushparaji et al, 2020, Current Treatment Options in Cardiovascular Medicine CrossRef
4. Receptor tyrosine kinase inhibitors negatively impact on pro-reparative characteristics of human cardiac progenitor cells
   Andrew J. Smith et al, 2022, Scientific Reports CrossRef